Barbara A. Burrall, M.D. for UC Davis Health

Barbara A. Burrall, M.D.

Clinical Medical Director

Editor in Chief, Dermatology Online Journal

Health Sciences Clinical Professor, Department of Dermatology

To see if Barbara A. Burrall is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).






Locations and Contact

Cannery Building

3301 C St.
Sacramento, CA 95816

Get Directions

Phone: 916-734-6111

Additional Numbers

Clinic Fax


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Burrall finds dermatology very interesting - and fun - because it combines the study of many diverse fields of medicine. With dermatologic disease, treatment decisions are often influenced by the patient's feelings about the disease, so she tries to include her patients actively in the decision-making process and the treatment plan. Good dermatological health requires avoidance of excessive sun exposure. Using good sun protection also proves extremely beneficial. Overall good patient care necessitates cooperation among different specialists and the primary care doctor, a good working relationship that focuses on the patient. Dr. Burrall has been associated with UC Davis since 1981, and enjoys collaborating with physicians from many other specialties to provide outstanding care for her patients.

Clinical Interests

Dr. Burrall is a general, medical dermatologist with more than 30 years of experience in the practice of dermatology.

Research/Academic Interests

Dr. Burrall's academic interests include teaching students and residents. In addition, she has been Editor-in-Chief of Dermatology Online Journal for more than 20 years. She is also currently the Residency Program Director.



Undergraduate School

B.S., UCLA, Los Angeles CA 1976

Medical School

M.D., UC Irvine College of Medicine, Irvine CA 1980


San Joaquin General Hospital, Stockton CA 1980-1981


Dermatology, UC Davis Medical Center, Sacramento CA 1981-1984

Physician Scientist Award-National Institute of Allergy and Infectious Disease, NIH, 1985

Bank of America-Giannini Foundation Medical Fellow, 1983

Medical Scholar Award, UC Davis, 1982

Departmental Honors, Biochemistry, UCLA, 1976

Magna Cum Laude, Biochemistry, UCLA, 1976

Liakos W, Burrall BA, Hsu DK, Cohen PR. Social media (SoMe) enhances exposure of dermatology articles. Dermatol Online J. 2021 Jul 15;27(7). doi:10.5070/D327754361. PMID:34391326.

Vy M, Mehrzad M, Konia T, Burrall B. An unusual case of multiple grouped non-familial trichoepitheliomas. Dermatol Online J. 2021 May 15;27(5). doi:10.5070/D327553615. PMID:34118815.

Wang JZ, Pourang A, Burrall B. Open access medical journals: Benefits and challenges. Clin Dermatol. 2019 Jan-Feb;37(1):52-55. doi:10.1016/j.clindermatol.2018.09.010. Epub 2018 Sep 15. PMID:30554623.

Bartos G, Cline A, Beroukhim K, Burrall BA, Feldman SR. Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review. Dermatol Online J. 2018 Nov 15;24(11):13030/qt3db748cg. PMID:30695971.

Singh S, Gorouhi F, Konia T, Burrall B. Pancreatic acinar cell carcinoma-induced panniculitis. JAAD Case Rep. 2018 Aug 15;4(7):719-721. doi:10.1016/j.jdcr.2018.05.003. PMID:30128347.

Hassoun LA, Sivamani RK, Sharon VR, Silverstein MA, Burrall BA, Tartar DM. Ustekinumab to target granulomatous dermatitis in recalcitrant ulcerative necrobiosis lipoidica: case report and proposed mechanism. Dermatol Online J. 2017 Jul 15;23(7):13030/qt3k32k916. PMID:29469709.

Sukhov A, Burrall B, Maverakis E. The history of open access medical publishing: a comprehensive review. Dermatol Online J. 2016 Sep 15;22(9):13030/qt6578w9f8. PMID:28329604.

Lim YH, Qiu J, Saraceni C, Burrall BA, Choate KA. Genetic Reversion via Mitotic Recombination in Ichthyosis with Confetti due to a KRT10 Polyalanine Frameshift Mutation. J Invest Dermatol. 2016 Aug;136(8):1725-1728. doi:10.1016/j.jid.2016.04.023. Epub 2016 May 18. PMID:27208707.

Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series. J Am Acad Dermatol. 2015 Oct;73(4):645-54. doi:10.1016/j.jaad.2015.06.060. Epub 2015 Aug 7. PMID:26259990.

Maverakis E, Cornelius LA, Bowen GM, Phan T, Patel FB, Fitzmaurice S, He Y, Burrall B, Duong C, Kloxin AM, Sultani H, Wilken R, Martinez SR, Patel F. Metastatic melanoma - a review of current and future treatment options. Acta Derm Venereol. 2015 May;95(5):516-24. doi:10.2340/00015555-2035. PMID:25520039.